SI1592408T1 - Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev - Google Patents

Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev

Info

Publication number
SI1592408T1
SI1592408T1 SI200431291T SI200431291T SI1592408T1 SI 1592408 T1 SI1592408 T1 SI 1592408T1 SI 200431291 T SI200431291 T SI 200431291T SI 200431291 T SI200431291 T SI 200431291T SI 1592408 T1 SI1592408 T1 SI 1592408T1
Authority
SI
Slovenia
Prior art keywords
sustained release
release device
ocular delivery
adrenergic agents
adrenergic
Prior art date
Application number
SI200431291T
Other languages
English (en)
Inventor
Paul Ashton
Hong Guo
Original Assignee
Psivida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psivida Inc filed Critical Psivida Inc
Publication of SI1592408T1 publication Critical patent/SI1592408T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
SI200431291T 2003-01-24 2004-01-23 Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev SI1592408T1 (sl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US44249903P 2003-01-24 2003-01-24
US48331603P 2003-06-26 2003-06-26
US48267703P 2003-06-26 2003-06-26
US50197403P 2003-09-11 2003-09-11
PCT/US2004/001718 WO2004066979A2 (en) 2003-01-24 2004-01-23 Sustained release device and method for ocular delivery of adrenergic agents
EP04704837A EP1592408B1 (en) 2003-01-24 2004-01-23 Sustained release device and method for ocular delivery of adrenergic agents

Publications (1)

Publication Number Publication Date
SI1592408T1 true SI1592408T1 (sl) 2010-01-29

Family

ID=32831098

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431291T SI1592408T1 (sl) 2003-01-24 2004-01-23 Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev

Country Status (15)

Country Link
EP (1) EP1592408B1 (sl)
JP (1) JP2006516618A (sl)
KR (1) KR20050118161A (sl)
AR (1) AR042917A1 (sl)
AT (1) ATE440595T1 (sl)
AU (1) AU2004207506B2 (sl)
BR (1) BRPI0406879B1 (sl)
CA (1) CA2513751C (sl)
DE (1) DE602004022776D1 (sl)
DK (1) DK1592408T3 (sl)
ES (1) ES2332720T3 (sl)
MX (1) MXPA05007719A (sl)
SI (1) SI1592408T1 (sl)
TW (1) TWI356714B (sl)
WO (1) WO2004066979A2 (sl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004066980A2 (en) * 2003-01-24 2004-08-12 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
EP2377569A1 (en) 2004-07-02 2011-10-19 QLT Plug Delivery, Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
US8795711B2 (en) * 2006-03-31 2014-08-05 Mati Therapeutics Inc. Drug delivery methods, structures, and compositions for nasolacrimal system
US9173773B2 (en) 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
SG138567A1 (en) * 2006-06-21 2008-01-28 Johnson & Johnson Vision Care Punctal plugs for the delivery of active agents
FR2906712A1 (fr) * 2006-10-09 2008-04-11 France Chirurgie Instr Bouchon meatique a pose simplifiee.
WO2008083118A1 (en) * 2006-12-26 2008-07-10 Qlt Plug Delivery, Inc. Drug delivery implants for inhibition of optical defects
ES2533359T3 (es) * 2007-09-07 2015-04-09 Mati Therapeutics Inc. Núcleos de fármaco para liberación sostenida de agentes terapéuticos
AU2008296872A1 (en) * 2007-09-07 2009-03-12 Qlt Inc. Lacrimal implants and related methods
US20090264477A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US9949942B2 (en) * 2008-05-09 2018-04-24 Mati Therapeutics Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
TW201012469A (en) * 2008-06-24 2010-04-01 Qlt Plug Delivery Inc Combination treatment of glaucoma
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
EP2376019A1 (en) * 2008-12-19 2011-10-19 QLT, Inc. Substance delivering punctum implants and methods
CN102271632A (zh) * 2009-01-02 2011-12-07 爱尔康研究有限公司 可原位再填充的眼植入物
CN102724951A (zh) 2009-11-09 2012-10-10 阿勒根公司 用于刺激毛发生长的组合物和方法
EP2555749B1 (en) * 2010-04-06 2016-10-26 Allergan, Inc. Sustained-release reservoir implants for intracameral drug delivery
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
ES2666857T3 (es) 2011-07-18 2018-05-08 Mor-Research Applications Ltd. Un dispositivo para ajustar la presión intraocular
KR20150119254A (ko) 2013-02-15 2015-10-23 알러간, 인코포레이티드 지속된 약물 전달 임플란트
WO2018231811A1 (en) * 2017-06-13 2018-12-20 EyePoint Pharmaceuticals, Inc. Bioerodible drug delivery devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6196993B1 (en) * 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof

Also Published As

Publication number Publication date
DK1592408T3 (da) 2010-01-04
CA2513751C (en) 2012-01-10
ATE440595T1 (de) 2009-09-15
BRPI0406879B1 (pt) 2015-12-22
TW200500099A (en) 2005-01-01
TWI356714B (en) 2012-01-21
EP1592408A2 (en) 2005-11-09
AU2004207506B2 (en) 2009-10-08
MXPA05007719A (es) 2005-09-30
WO2004066979A3 (en) 2004-09-16
AR042917A1 (es) 2005-07-06
KR20050118161A (ko) 2005-12-15
EP1592408B1 (en) 2009-08-26
CA2513751A1 (en) 2004-08-12
BRPI0406879A (pt) 2006-01-03
ES2332720T3 (es) 2010-02-11
DE602004022776D1 (de) 2009-10-08
JP2006516618A (ja) 2006-07-06
AU2004207506A1 (en) 2004-08-12
WO2004066979A2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
SI1592408T1 (sl) Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev
EP1539065A4 (en) METHOD AND APPARATUS FOR THE DISPOSAL OF EYE IMPLANTS
EP1708780A4 (en) DISTRIBUTION DEVICE AND DISTRIBUTION METHOD
HK1254943A1 (zh) 治療藥物遞送裝置和方法
TWI345987B (en) Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
TWI369975B (en) Improved apparatus for delivery of ocular implants
GB0301934D0 (en) Delivery apparatus and location method
EP1638639A4 (en) DRUG DELIVERY METHOD AND METHOD
GB0307082D0 (en) Drug delivery device and method
EP1809200A4 (en) DEVICE AND METHOD FOR PROVIDING ORAL CARE AGENT
GB0519316D0 (en) "Method and apparatus"
EP1377232A4 (en) OCULAR DEVICES FOR DELIVERY OF THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SUCH DEVICES
EP1670375A4 (en) METHOD AND DEVICE FOR IMPROVED HORNHAUS COUGH MODULATION
IL183964A0 (en) System and method for identifying and controlling ophthalmic surgical devices and components
PL1543851T3 (pl) Wszczepialne urządzenie do podawania substancji czynnej
EP1771140A4 (en) METHOD AND DEVICE FOR OPTICAL OPHTHALMIC THERAPY
EP1740193A4 (en) MACROMOLEKULOUS INTRAOCULAR IMPLANTS WITH DELAYED RELEASE AND CORRESPONDING METHODS
EP1680008A4 (en) DEVICES AND METHODS FOR FIXED-POSITION STENT INSTALLATION
HK1144713A1 (en) Apparatus and methods for providing sex-sorted animal sperm
EP1684669A4 (en) DEVICE FOR RELEASING AN OPHTHALMIC MEDICINAL PRODUCT
ZA200507151B (en) Apparatus and methods for providing sex-sorted animal sperm
IL188737A0 (en) Delivery system and method of use for deployment of self-expandable vascular device
PL1620049T3 (pl) Urządzenie do cięcia rogówki oka
EP1618838A4 (en) DEVICE FOR MONITORING THE EYE BACKGROUNDS AND METHOD FOR OBSERVING THE EYES BACKGROUND
EP1658109A4 (en) OCCUPANT MEDICINAL TOOL EQUIPMENT